Skip to main content
Veterinary Medicines

EFFIPRO DUO 402 MG/120 MG SPOT-ON SOLUTION FOR VERY LARGE DOGS

Authorised
  • Fipronil
  • Pyriproxyfen

Product identification

Medicine name:
EFFIPRO DUO 402 MG/120 MG SPOT-ON SOLUTION FOR VERY LARGE DOGS
Effipro Duo 402 mg/120 mg užlašinamasis tirpalas labai dideliems šunims
Active substance:
  • Fipronil
  • Pyriproxyfen
Target species:
  • Dog
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Fipronil
    402.00
    milligram(s)
    /
    1.00
    Pipette
  • Pyriproxyfen
    120.60
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Withdrawal period by route of administration:
  • Cutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX65
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:
  • Box containing 1 pipette of 4.02 mL
  • Box containing 4 pipettes of 4.02 mL
  • Box containing 24 pipettes of 4.02 mL
  • Box containing 60 pipettes of 4.02 mL

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/15/2304/013-016
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0402/004
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

RV2304-4.pdf

Lithuanian (PDF)
Published on: 31/05/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."